Test Bank:
zi
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest E
zi zi zi zi zi zi zi zi zi
dition, 2024
zi
, Table of Contents zi zi
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
zi zi zi zi zi zi zi zi
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
zi zi zi zi
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
zi zi zi
Chapter 5: Pharmacology Across the Life Span......................................................................................... 30
zi zi zi zi zi zi
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
zi zi zi zi zi zi
Chapter 7: Drug Development and Approval............................................................................................. 45
zi zi zi zi zi
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
zi zi zi zi zi zi zi zi zi
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
zi zi zi zi zi
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
zi zi zi zi zi
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
zi zi zi zi zi zi zi zi zi
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
zi zi zi zi zi zi zi zi zi zi zi zi
14: Pharmacotherapy for Eye Conditions .................................................................................................... 67
zi zi zi zi
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................... 74
zi zi zi zi zi
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
zi zi zi zi zi
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
zi zi zi zi zi
Chapter 18: Pharmacotherapy for Respiratory Conditions ...................................................................... 106
zi zi zi zi zi
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
zi zi zi zi zi zi zi zi zi
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
zi zi zi zi zi
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders......................... 133
zi zi zi zi zi zi zi zi zi
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
zi zi zi zi zi zi zi
Chapter 23: Therapeutic Applications of Immunology and Vaccines .................................................... 158
zi zi zi zi zi zi zi
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
zi zi zi zi zi
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
zi zi zi zi zi
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
zi zi zi zi zi zi zi zi
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................. 196
zi zi zi zi zi zi zi
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions....................................................... 211
zi zi zi zi zi zi zi
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................... 217
zi zi zi zi zi zi
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
zi zi zi
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
zi zi zi
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
zi zi zi zi zi zi zi zi zi zi
ognitive Conditions .................................................................................................................................... 247
zi
Chapter 33: Pharmacotherapy for Pain Management............................................................................... 257
zi zi zi zi zi
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
zi zi zi zi zi zi zi zi zi
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
zi zi zi
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
zi zi zi zi
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
zi zi zi zi zi zi zi zi
MULTIPLE CHOICE zi
• What is the primary purpose of the nursing assessment?
zi zi zi zi zi zi zi zi
A. Identifying underlying pathologic conditions zi zi zi
B. Assisting the physician in identifying medical conditions zi zi zi zi zi zi
C. Determining the patients mental status zi zi zi zi
D. Exploring patient responses to health problems zi zi zi zi zi
ANS: D zi
A nursing assessment is done to identify the patients response to health pro
zi zi zi zi zi zi zi zi zi zi zi zi
blems. During the nursing assessment phase, a comprehensive information
zi zi zi zi zi zi zi zi z
base is developed through a physical examination, nursing history, medica
i zi zi zi zi zi zi zi zi zi
tion history, and professional observation. Identifying underlying patholog
zi zi zi zi zi zi zi
ic conditions and assisting the physician in identifying medical conditions
zi zi zi zi zi zi zi zi zi zi
is not part of the nursing process. Determining the patients mental status i
zi zi zi zi zi zi zi zi zi zi zi zi
s one part of the nursing assessment, but it is not the primary purpose.
zi zi zi zi zi zi zi zi zi zi zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi zi
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
zi zi zi zi zi zi zi zi zi
Process Step: Assessment zi zi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
zi zi zi zi zi zi zi zi
• What is the basis of the NANDA I taxonomy?
zi zi zi zi zi zi zi z i
A. Functional health patterns zi zi
B. Human response patterns zi zi
C. Basic human needs zi zi
D. Pathophysiologic needs zi
ANS: B zi
The NANDA I taxonomy identifies human response patterns. Funct
z i z i z i z i z i z i z i zi
ional components of health patterns are limited to activity, fluid volume,
zi zi zi zi zi zi zi zi zi zi zi
nutrition, self care, and sensory perception. Basic human needs comprise
zi zi zi zi zi zi zi zi zi zi
less than merely health patterns. Pathophysiologic needs are not part of
zi zi zi zi zi zi zi z i zi zi zi
the scope of NANDA I.
zi zi zi zi
, DIF: Cognitive Level: Knowledge RE
zi zi zi zi
F: pp. 37-38 OBJ: 5 TOP:
zi zi zi zi zi
Nursing Process Step: Diagnosis
zi zi zi
MSC: NCLEX Client Needs Category: Physiological Integrity
zi zi zi zi zi zi
• Which task is included in the assessment step of the nursing process?
zi zi zi zi zi zi zi zi zi zi zi
A. Establishing patient goals/outcomes zi zi
B. Implementing the nursing care plan (NCP) zi zi zi zi zi
C. Measuring goal/outcome achievement zi zi
D. Collecting and communicating data zi zi zi
ANS: D zi
Data are collected and communicated in the assessment phase of the nursi
zi zi zi zi zi zi zi zi zi zi zi
ng process. Establishing goals is the function of planning.
zi zi zi zi zi zi zi zi
Implementing the NCP is the function of implementation. Measuring outc
zi zi zi zi zi zi zi zi zi
ome achievement is the function of evaluation.
zi zi zi zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi zi
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
zi zi zi zi zi zi zi zi zi
Process Step: Assessment zi zi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
zi zi zi zi zi zi zi zi
• Which statement regarding nursing diagnoses is accurate?
zi zi zi zi zi zi
a. Nursing diagnoses remain the same for as long as the disease is present.
zi zi zi zi zi zi zi zi zi zi zi zi
b. Nursing diagnoses are written to identify disease states. zi zi zi zi zi zi zi
c. Nursing diagnoses describe patient problems that nurses treat.
zi zi zi zi zi zi zi
d. Nursing diagnoses identify causes related to illness. zi zi zi zi zi zi
ANS: C zi
Diagnostic statements identify problems a nurse is independently able to t
zi zi zi zi zi zi zi zi zi zi
reat within the scope of professional practice. Nursing diagnoses vary wit
zi zi zi zi zi zi zi zi zi zi
h the changing condition of the patient. The response patterns are unique t
zi zi zi zi zi zi zi zi zi zi zi zi
o the patient and are not disease specific. Nursing diagnoses describe the
zi zi zi zi zi zi zi zi zi zi zi zi
patients human response pattern.
zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi
zi
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest E
zi zi zi zi zi zi zi zi zi
dition, 2024
zi
, Table of Contents zi zi
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
zi zi zi zi zi zi zi zi
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
zi zi zi zi
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
zi zi zi
Chapter 5: Pharmacology Across the Life Span......................................................................................... 30
zi zi zi zi zi zi
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
zi zi zi zi zi zi
Chapter 7: Drug Development and Approval............................................................................................. 45
zi zi zi zi zi
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
zi zi zi zi zi zi zi zi zi
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
zi zi zi zi zi
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
zi zi zi zi zi
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
zi zi zi zi zi zi zi zi zi
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
zi zi zi zi zi zi zi zi zi zi zi zi
14: Pharmacotherapy for Eye Conditions .................................................................................................... 67
zi zi zi zi
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................... 74
zi zi zi zi zi
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
zi zi zi zi zi
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
zi zi zi zi zi
Chapter 18: Pharmacotherapy for Respiratory Conditions ...................................................................... 106
zi zi zi zi zi
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
zi zi zi zi zi zi zi zi zi
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
zi zi zi zi zi
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders......................... 133
zi zi zi zi zi zi zi zi zi
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
zi zi zi zi zi zi zi
Chapter 23: Therapeutic Applications of Immunology and Vaccines .................................................... 158
zi zi zi zi zi zi zi
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
zi zi zi zi zi
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
zi zi zi zi zi
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
zi zi zi zi zi zi zi zi
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................. 196
zi zi zi zi zi zi zi
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions....................................................... 211
zi zi zi zi zi zi zi
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................... 217
zi zi zi zi zi zi
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
zi zi zi
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
zi zi zi
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
zi zi zi zi zi zi zi zi zi zi
ognitive Conditions .................................................................................................................................... 247
zi
Chapter 33: Pharmacotherapy for Pain Management............................................................................... 257
zi zi zi zi zi
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
zi zi zi zi zi zi zi zi zi
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
zi zi zi
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
zi zi zi zi
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
zi zi zi zi zi zi zi zi
MULTIPLE CHOICE zi
• What is the primary purpose of the nursing assessment?
zi zi zi zi zi zi zi zi
A. Identifying underlying pathologic conditions zi zi zi
B. Assisting the physician in identifying medical conditions zi zi zi zi zi zi
C. Determining the patients mental status zi zi zi zi
D. Exploring patient responses to health problems zi zi zi zi zi
ANS: D zi
A nursing assessment is done to identify the patients response to health pro
zi zi zi zi zi zi zi zi zi zi zi zi
blems. During the nursing assessment phase, a comprehensive information
zi zi zi zi zi zi zi zi z
base is developed through a physical examination, nursing history, medica
i zi zi zi zi zi zi zi zi zi
tion history, and professional observation. Identifying underlying patholog
zi zi zi zi zi zi zi
ic conditions and assisting the physician in identifying medical conditions
zi zi zi zi zi zi zi zi zi zi
is not part of the nursing process. Determining the patients mental status i
zi zi zi zi zi zi zi zi zi zi zi zi
s one part of the nursing assessment, but it is not the primary purpose.
zi zi zi zi zi zi zi zi zi zi zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi zi
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
zi zi zi zi zi zi zi zi zi
Process Step: Assessment zi zi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
zi zi zi zi zi zi zi zi
• What is the basis of the NANDA I taxonomy?
zi zi zi zi zi zi zi z i
A. Functional health patterns zi zi
B. Human response patterns zi zi
C. Basic human needs zi zi
D. Pathophysiologic needs zi
ANS: B zi
The NANDA I taxonomy identifies human response patterns. Funct
z i z i z i z i z i z i z i zi
ional components of health patterns are limited to activity, fluid volume,
zi zi zi zi zi zi zi zi zi zi zi
nutrition, self care, and sensory perception. Basic human needs comprise
zi zi zi zi zi zi zi zi zi zi
less than merely health patterns. Pathophysiologic needs are not part of
zi zi zi zi zi zi zi z i zi zi zi
the scope of NANDA I.
zi zi zi zi
, DIF: Cognitive Level: Knowledge RE
zi zi zi zi
F: pp. 37-38 OBJ: 5 TOP:
zi zi zi zi zi
Nursing Process Step: Diagnosis
zi zi zi
MSC: NCLEX Client Needs Category: Physiological Integrity
zi zi zi zi zi zi
• Which task is included in the assessment step of the nursing process?
zi zi zi zi zi zi zi zi zi zi zi
A. Establishing patient goals/outcomes zi zi
B. Implementing the nursing care plan (NCP) zi zi zi zi zi
C. Measuring goal/outcome achievement zi zi
D. Collecting and communicating data zi zi zi
ANS: D zi
Data are collected and communicated in the assessment phase of the nursi
zi zi zi zi zi zi zi zi zi zi zi
ng process. Establishing goals is the function of planning.
zi zi zi zi zi zi zi zi
Implementing the NCP is the function of implementation. Measuring outc
zi zi zi zi zi zi zi zi zi
ome achievement is the function of evaluation.
zi zi zi zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi zi
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
zi zi zi zi zi zi zi zi zi
Process Step: Assessment zi zi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
zi zi zi zi zi zi zi zi
• Which statement regarding nursing diagnoses is accurate?
zi zi zi zi zi zi
a. Nursing diagnoses remain the same for as long as the disease is present.
zi zi zi zi zi zi zi zi zi zi zi zi
b. Nursing diagnoses are written to identify disease states. zi zi zi zi zi zi zi
c. Nursing diagnoses describe patient problems that nurses treat.
zi zi zi zi zi zi zi
d. Nursing diagnoses identify causes related to illness. zi zi zi zi zi zi
ANS: C zi
Diagnostic statements identify problems a nurse is independently able to t
zi zi zi zi zi zi zi zi zi zi
reat within the scope of professional practice. Nursing diagnoses vary wit
zi zi zi zi zi zi zi zi zi zi
h the changing condition of the patient. The response patterns are unique t
zi zi zi zi zi zi zi zi zi zi zi zi
o the patient and are not disease specific. Nursing diagnoses describe the
zi zi zi zi zi zi zi zi zi zi zi zi
patients human response pattern.
zi zi zi
DIF: Cognitive Level: Comprehension
zi zi zi
